A citation-based method for searching scientific literature

Gregory P Kalemkerian, Navneet Narula, Erin B Kennedy, William A Biermann, Jessica Donington, Natasha B Leighl, Madelyn Lew, James Pantelas, Suresh S Ramalingam, Martin Reck, Anjali Saqi, Michael Simoff, Navneet Singh, Baskaran Sundaram. J Clin Oncol 2018
Times Cited: 194

Tony S Mok, Yi-Long Wu, Myung-Ju Ahn, Marina C Garassino, Hye R Kim, Suresh S Ramalingam, Frances A Shepherd, Yong He, Hiroaki Akamatsu, Willemijn S M E Theelen, Chee K Lee, Martin Sebastian, Alison Templeton, Helen Mann, Marcelo Marotti, Serban Ghiorghiu, Vassiliki A Papadimitrakopoulou. N Engl J Med 2017
Times Cited: 1451

List of shared articles

Times cited

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Nasser H Hanna, Andrew G Robinson, Sarah Temin, Sherman Baker, Julie R Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain,[...]. J Clin Oncol 2021

Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective.
Umberto Malapelle, Sara Pilotto, Francesco Passiglia, Francesco Pepe, Pasquale Pisapia, Luisella Righi, Angela Listì, Paolo Bironzo, Lorenzo Belluomini, Fabrizio Tabbò,[...]. Crit Rev Oncol Hematol 2021

Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung Cancer.
Jhanelle Gray, Jeffrey C Thompson, Erica L Carpenter, Ehab Elkhouly, Charu Aggarwal. Oncologist 2021

Lung cancer.
Alesha A Thai, Benjamin J Solomon, Lecia V Sequist, Justin F Gainor, Rebecca S Heist. Lancet 2021

Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.
Nikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, Daniel Kazdal, Martina Kirchner, Felix J Herth, Claus-Peter Heussel, Florian Eichhorn, Michael Meister, Thomas Muley,[...]. Ther Adv Med Oncol 2021

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
P Garrido, E Conde, J de Castro, J J Gómez-Román, E Felip, L Pijuan, D Isla, J Sanz, L Paz-Ares, F López-Ríos. Clin Transl Oncol 2020

Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics.
Wei Guo, Sijin Sun, Lei Guo, Peng Song, Xuemin Xue, Hao Zhang, Guochao Zhang, Renda Li, Yibo Gao, Bin Qiu,[...]. DNA Cell Biol 2020

Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review.
Stepan M Esagian, Georgia Ι Grigoriadou, Ilias P Nikas, Vasileios Boikou, Peter M Sadow, Jae-Kyung Won, Konstantinos P Economopoulos. J Cancer Res Clin Oncol 2020

Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patients.
Chuanhao Tang, Lingxiang Zhu, Lijuan Zhang, Chianru Tan, Zhiyong Peng, Baoxia Liu, Wenjing Liu, Haixu Hu, Yu Bai, Bo Wang,[...]. Clin Chim Acta 2020

[Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Fernando López-Ríos, Luis Paz-Ares, Julián Sanz, Dolores Isla, Lara Pijuan, Enriqueta Felip, José Javier Gómez-Román, Javier de Castro, Esther Conde, Pilar Garrido. Rev Esp Patol 2020